That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...
Researchers have given the gene therapy made at UManchester to two out of five planned patients in a Phase I/II trial, and ...
High-resolution structures explain the mechanism of human PNPase and provide insights into mutations causing hereditary ...
Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 10 (Mar. 10, 2009), pp. 3764-3769 (6 pages) We report a computational, structure-based redesign of the ...
The ADA2 gene provides instructions for making an enzyme called adenosine deaminase 2. ADA2’s function has been poorly understood. Previous studies suggest that the enzyme acts as a growth factor. The ...
PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using ...
PORTLAND, OR – Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback